Ocular toxoplasmosis is a major cause of
blindness world-wide. Ocular involvement is frequently seen following congenital
infection. Many of these
infections are quiescent but pose a life-time risk of reactivation. However, the physiopathology of
ocular toxoplasmosis reactivation is largely unexplored. We previously developed a Swiss-Webster outbred mouse model for
congenital toxoplasmosis by neonatal injection of Toxoplasma gondii
cysts. We also used a mouse model of direct intraocular
infection to show a deleterious local T helper 17 type response upon primary
infection. In the present study, our two models were combined to study intravitreal re-challenge of neonatally infected mice, as an approximate model of reactivation, in comparison with a primary
ocular infection. Using
BioPlex proteomic assays in aqueous humour and reverse transcription-PCR for T helper cell
transcription factors, we observed diminished T helper 17 type reaction in
reinfection, compared with primary
infection. In contrast, T helper 2 and T regulatory responses were enhanced. Interestingly, this was also true for T helper 1 markers such as IFN-γ, which was paralleled by better parasite control. Secretion of
IL-27, a central
cytokine for shifting the immune response from T helper 17 to T helper 1, was also greatly enhanced. We observed a similar protective immune reaction pattern in the eye upon
reinfection with the virulent RH strain, with the notable exception of IFN-γ. In summary, our results show that the balance is shifted from T helper 17 to a less pathogenic but more effective anti-parasite Treg/T helper 1/T helper 2 pattern in a reactivation setting.